{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:38:39Z","timestamp":1791067119125,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.nbd.2008.12.017","type":"journal-article","created":{"date-parts":[[2009,1,10]],"date-time":"2009-01-10T06:11:02Z","timestamp":1231567862000},"page":"78-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Glutamate toxicity in the striatum of the R6\/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters"],"prefix":"10.1016","volume":"34","author":[{"given":"Ana Mar\u00eda","family":"Estrada-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Montiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Massieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2008.12.017_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000091921","article-title":"Changes in expression of N-methyl-d-aspartate receptor subunits occur early in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Ali","year":"2006","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.nbd.2008.12.017_bib2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT-1) mRNA expression in Huntington's disease-an in situ hybridization study","volume":"56","author":"Arzberger","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.12.017_bib3","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.12.017_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-7091-0579-5_14","article-title":"The N-methyl-d-aspartate antagonist memantine retards progression of Huntington's disease","volume":"68","author":"Beister","year":"2004","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.nbd.2008.12.017_bib5","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1046\/j.1471-4159.1998.71062642.x","article-title":"Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease","volume":"71","author":"Bogdanov","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.12.017_bib6","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","article-title":"Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease","volume":"79","author":"Bogdanov","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.12.017_bib7","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2008.12.017_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.12.017_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuroscience.2006.12.069","article-title":"Sustained metabolic inhibition induces an increase in the content and phosphorylation of the NR2B subunit of N-methyl-d-aspartate receptors and a decrease in glutamate transport in the rat hippocampus in vivo","volume":"145","author":"Camacho","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2008.12.017_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington's disease","volume":"66","author":"Cepeda","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.12.017_bib11","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2008.12.017_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2008.12.017_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.12.017_bib14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.12.017_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.12.017_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington's disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.12.017_bib17","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.12.017_bib18","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioral deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2008.12.017_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington's disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2008.12.017_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.12.017_bib21","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s100720200081","article-title":"Amantadine in Huntington's disease: open-label video-blinded study","volume":"23","author":"Lucetti","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2008.12.017_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jnr.10100","article-title":"Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice","volume":"67","author":"MacGibbon","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.12.017_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.12.017_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.12.017_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2008.12.017_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0361-9230(00)00238-0","article-title":"Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity","volume":"52","author":"Morton","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2008.12.017_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.0953-816X.2000.01379.x","article-title":"Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6\/1 Huntington transgenic mice","volume":"13","author":"Nicniocaill","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2008.12.017_bib28","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.nbd.2008.12.017_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(00)02082-5","article-title":"Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease","volume":"862","author":"P\u00e9rez-Severiano","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2008.12.017_bib30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in R6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.nbd.2008.12.017_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role of astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.12.017_bib32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.12.017_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2008.12.017_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0076-6879(02)53061-5","article-title":"Transgenic model for the study of oxidative damage in Huntington's disease","volume":"353","author":"Segovia","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.nbd.2008.12.017_bib35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2008.12.017_bib36","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.12.017_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","article-title":"Alteration in N-methyl-d-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington's disease","volume":"82","author":"Starling","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.12.017_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2008.12.017_bib39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.12.017_bib40","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1097\/WNR.0b013e3282f262ca","article-title":"Reduced activity of cortico-striatal fibers in the R6\/2 mouse model of Huntington's disease","volume":"18","author":"Traficante","year":"2007","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2008.12.017_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington Disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Exp. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.12.017_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.12.017_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2008.12.017_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.cdd.4402261","article-title":"Mutant huntingtin can paradoxically protect neurons from cell death","volume":"15","author":"Zuchner","year":"2008","journal-title":"Cell Death Differ."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108003148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108003148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:03:46Z","timestamp":1760850226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108003148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0969996108003148"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.12.017","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamate toxicity in the striatum of the R6\/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}